In a remarkable breakthrough that could fundamentally transform how light is delivered within biological tissues, researchers at Stanford University have developed a novel, noninvasive technique to generate precise points of light deep inside the body. Published on April 13, 2026, in Nature Materials, this pioneering work capitalizes on the unique properties of carefully engineered nanomaterials in tandem with ultrasound waves, opening a horizon of possibilities for biomedical applications ranging from neural modulation to targeted cancer therapies.
The penetration of light in living tissues has long posed a substantial challenge for scientists and clinicians alike. Whereas visible light readily interacts with and is absorbed by cells and molecules, its limited ability to traverse layers of dense tissue restricts therapeutic and diagnostic interventions to superficial or surgically exposed regions. Historically, invasive methods—such as surgically implanting optical fibers or opening tissue windows—have been necessary to deliver light to deeper anatomical structures. The Stanford team, led by assistant professor Guosong Hong from the School of Engineering’s Department of Materials Science and Engineering, sought to circumvent these issues by harnessing the deep penetrating power of ultrasound.
Ultrasound, typically used in medical imaging, can propagate through various tissue types far more effectively than light, making it a compelling tool for remote activation within the body. Hong and colleagues innovatively combined ultrasound with novel nanomaterials—originally ceramic particles known for their mechanical and optical properties—to create light-emitting nanoparticles that respond to mechanical stress. These engineered nanomaterials, once injected into the bloodstream, distribute systemically and remain quiescent until selectively activated by externally focused ultrasound waves.
The initial challenge lay in transforming bulk ceramic particles into biocompatible nanoparticles that could circulate safely in vivo. The team refined their fabrication process to generate nanoparticles with a specialized coating, ensuring stability within biological fluids and minimizing immune clearance. Upon administration into murine models, these particles disseminated through the vasculature, infiltrating essentially every organ system. The nanoparticles emit blue light at approximately 490 nanometers in wavelength exclusively when subjected to the localized mechanical excitation from focused ultrasound, thereby achieving a remarkable level of spatial precision.
One of the most striking demonstrations involved the creation of tiny ultrasound-generating devices—the researchers dubbed these ultrasound ‘hats’—worn by mice, allowing the noninvasive stimulation of distinct brain regions. Depending on the site of ultrasound focus, different neuronal circuits were activated, eliciting behavioral responses such as directional turning. This validated the concept that ultrasonic stimulation of these nanoparticles can functionally manipulate neuronal activity with exquisite targeting accuracy, bypassing the need for implanted optical fibers, viral vector injections, or genetic modifications traditionally employed in optogenetics.
Beyond neural applications, the implications extend to photodynamic therapy, where blue light is instrumental in activating photosensitive compounds to selectively destroy malignant cells. The team’s method circumvents the conventional obstacles of delivering specific wavelengths to tumors embedded deep within tissues. Moreover, ongoing experiments are expanding the technique’s versatility by investigating nanomaterials capable of emitting ultraviolet light under ultrasound stimulation—a wavelength known for potent antimicrobial effects, potentially broadening the therapeutic repertoire for infectious diseases.
The Stanford team is also collaborating closely with experts in gene editing, including neurobiology and bioengineering professor Michael Lin, to integrate these technology platforms. The goal is to achieve unprecedented spatiotemporal control over gene-editing mechanisms such as CRISPR. By harnessing ultrasound to trigger light-activated gene editors only in designated tissue regions, this approach promises to diminish off-target genetic modifications, paving the way for safer, more precise gene therapies.
However, the researchers acknowledge that despite promising efficacy and a lack of immediate toxicity in rodent models, the ceramic nanoparticle-based system faces hurdles before clinical translation. The materials demonstrate persistence in biological tissues and potential accumulation in organs such as the liver, raising biocompatibility concerns. Addressing this, Hong’s team is actively searching for alternative materials that can biodegrade safely within the body without compromising optical and mechanical functionality.
What emerges from this work is a compelling proof of concept that unites the remote penetrative capabilities of ultrasound with nanoparticle-mediated light emission, creating programmable light sources inside living organisms without surgical intervention. This breakthrough could serve as a foundation for a new class of medical devices and treatments, potentially revolutionizing fields from neuroscience to oncology to regenerative medicine.
This interdisciplinary innovation epitomizes the frontier spirit of modern materials science and bioengineering, where the convergence of physics, chemistry, and biology yields unprecedented tools for health. Light delivery no longer needs to be limited by tissue opacity, ushering in a future where therapeutic photons can be summoned on demand to locations deep within the body, guided solely by ultrasound.
To fully unlock this technology’s clinical potential, further research must optimize nanomaterial safety profiles, refine ultrasound focusing mechanisms, and expand the palette of light wavelengths available. Yet the roadmap laid out by Hong and colleagues already signals a powerful new modality for minimally invasive therapies that could dramatically improve patient outcomes and reduce procedural complications.
As light and sound blend harmoniously inside the body through engineered nanoparticles, this spotlight on innovation illuminates a visionary path for biologically integrated photonic technologies. The era of ultrasound-controlled, in vivo light sources has arrived, promising to reshape biomedical science and redefine how we interact with the inner realms of living tissue.
Subject of Research: Ultrasound-induced light emission using nanoparticle systems for noninvasive biomedical applications.
Article Title: An ultrasound-scanning in vivo light source.
News Publication Date: 13-Apr-2026.
Web References: http://dx.doi.org/10.1038/s41563-026-02556-z
Keywords
Optics, Light, Nanoparticles, Ultrasound
Tags: advanced optical techniques in medicinebreakthroughs in biomedical engineeringnanomaterials for biomedical applicationsneural modulation with ultrasound-induced lightnoninvasive deep tissue light deliverynoninvasive optical therapy methodsovercoming light penetration limits in tissueStanford University ultrasound researchtargeted cancer therapies using ultrasoundultrasound and nanomaterial synergyultrasound for deep tissue imagingultrasound-generated light in biological tissues
